Voluntary announcement unusual price movements
Filed with HKEX · Stock code 2575 · · 2 pages · English
Xuanzhu Biopharmaceutical Co., Ltd. 軒竹生物科技股份有限公司 (a joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 2575) VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE MOVEMENTS This announcement is made by Xuanzhu Biopharmaceutical Co., Ltd. (“Company”, together with its subsidiaries, the “Group”) on a voluntary basis. UNUSUAL PRICE MOVEMENTS The board (the “Board”)
Xuanzhu Biopharmaceutical Co., Ltd. on 6ix
Earlier from Xuanzhu Biopharmaceutical
- 2025 Annual report - supplemental information
- 2026 Interim report
- Voluntary announcement first patient enrolled in phase III clinical trial of anaprazole sodium for helicobacter pylori eradication
- List of directors and their role and function
Later from Xuanzhu Biopharmaceutical
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
- Voluntary announcement phase iii clinical study data of anaprazole sodium for reflux esophagitis presented at ueg week 2026PRESENTED at ueg week 2026
Follow Xuanzhu Biopharmaceutical into a list and get an email when it puts out news.
Follow Xuanzhu Biopharmaceutical